Allogene Therapeutics, Inc. (ALLO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 09:40AM EDT. Market open.
| Previous close | 10.96 |
| Open | 10.89 |
| Bid | 0.00 x 1800 |
| Ask | 13.89 x 900 |
| Day's range | 10.80 - 12.18 |
| 52-week range | 6.43 - 20.75 |
| Volume | |
| Avg. volume | 1,670,762 |
| Market cap | 1.724B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Allogene Therapeutics (ALLO) Down 10.9% Since Last Earnings Report: Can It Rebound?
Allogene Therapeutics (ALLO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Simply Wall St.
Estimating The Intrinsic Value Of Allogene Therapeutics, Inc. (NASDAQ:ALLO)
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Allogene Therapeutics...
- Simply Wall St.
Is Allogene Therapeutics (NASDAQ:ALLO) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
© 2022 Yahoo. All rights reserved.
